Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

Practice Direction Letter

28 Oct 2021 12:09

RNS Number : 6045Q
CATCo Reinsurance Opps Fund Ltd
28 October 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION UNDER THE RETAINED UK LAW VERSION OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019 (SI 2019/310).

 

Markel CATCo Announces Commencement of Schemes of Arrangement for Investors in Markel CATCo Reinsurance Fund Ltd. and CATCo Reinsurance Opportunities Fund Ltd.

 

London 28 October 2021 - Further to its announcement on 26 October 2021, Markel CATCo Investment Management Ltd. (MCIM) is pleased to announce that Markel CATCo Reinsurance Fund Ltd. (provisional liquidators appointed) (the Private Fund) and CATCo Reinsurance Opportunities Fund Ltd. (provisional liquidators appointed) (the Public Fund, together with the Private Fund, the Funds) have now issued a joint Practice Direction Letter and commenced schemes of arrangement in Bermuda (Schemes) to implement the Buy-Out Transaction announced on 27 September 2021. The Practice Direction Letter provides information regarding the schemes of arrangement, and the Funds are mailing electronic or hard copies of the letter to all investors. The Practice Direction Letter is also available on the transaction website: https://catcobuyout.alixpartners.com. Further notice will be provided when a hearing is scheduled to consider the commencement of the Schemes and convening of Scheme meetings.

 

The person responsible for arranging release of this announcement is: Judith Wynne, Assistant Secretary to the Public Fund.

 

Disclaimers and important notices

This announcement is for information purposes only and is not intended to, and does not, constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Buy-Out Transaction or otherwise. The Schemes will be made solely pursuant to the terms of the scheme documents to be sent to investors in the Funds in due course. The scheme documents will contain the full terms and conditions of the Schemes, including details of how to vote in respect of them. Any decision in respect of, or other response to, the Schemes should be made only on the basis of the information in those documents. The information contained in this announcement is for background purposes only and no reliance may or should be placed by any person for any purpose whatsoever on the information contained in this announcement or on its completeness, accuracy or fairness. Recipients of this announcement should conduct their own investigation, evaluation and analysis of the business, data and property described in this announcement. This announcement does not constitute a recommendation concerning any investor's decision or options with respect to the Buy-Out Transaction. The information in this announcement is subject to change.

 

The distribution of this announcement and the terms of the Buy-Out Transaction are subject to restrictions and may not be made except pursuant to registration with or authorisation by the relevant securities regulatory authorities or an exemption therefrom. Therefore, persons who may come into possession of this announcement are advised to consult with their own legal advisors as to what restrictions may be applicable to them and to observe such restrictions. This announcement may not be used for the purpose of an offer or invitation in any circumstances in which such offer or invitation is not authorised.

 

No action has been or will be taken in any jurisdiction by the Funds that would or is intended to permit a public offering, or any other offering under circumstances not permitted by applicable law, of any securities.

 

Further to the above, the release, publication or distribution of this announcement in other jurisdictions may be restricted by law and therefore any persons who are subject to the laws of any applicable jurisdiction (including any jurisdiction where local laws or regulations may result in a significant risk of civil, regulatory or criminal exposure if information concerning the Buy-Out Transaction is sent or made available to investors in that jurisdiction (Restricted Jurisdictions)) should inform themselves about, and observe, any applicable legal or regulatory requirements. In particular, the ability of persons who are resident in such other jurisdictions or who are subject to the laws of another jurisdiction to participate in the Buy-Out Transaction may be affected by the laws of the relevant jurisdictions in which they are located or to which they are subject. Any failure to comply with applicable legal or regulatory requirements of any jurisdiction may constitute a violation of securities laws in that jurisdiction.

 

Copies of this announcement and any formal documentation relating to the Buy-Out Transaction are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in or into or from any Restricted Jurisdiction or any jurisdiction where to do so would constitute a violation of the laws of such jurisdiction and persons receiving such documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in or into or from any Restricted Jurisdiction. Doing so may render invalid any related purported vote in respect of the Buy-Out Transaction (or the related Schemes).

Certain of the statements in this announcement or (and any related oral statements) may be considered forward-looking statements

 

This announcement (including information incorporated by reference in this announcement), oral statements made regarding the Buy-Out Transaction, information accessed through https://catcobuyout.alixpartners.com and other information published by MCIM and the Funds contain statements which are, or may be deemed to be, "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995.

 

Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of the management of MCIM and the Funds about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. The forward-looking statements contained in this announcement include statements relating to the expected effects of the Buy-Out Transaction, the expected timing and scope of the Buy-Out Transaction and other statements other than historical facts. Often, but not always, forward-looking statements can be identified by the use of forward-looking words such as "plans", "expects" or "does not expect", "is expected", "is subject to", "budget", "projects", "strategy", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. Although MCIM and the Funds believe that the expectations reflected in such forward-looking statements are reasonable, they can give no assurance that such expectations will prove to be correct. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future.

 

There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. These factors include, but are not limited to: the ability to complete the Buy-Out Transaction; the ability to obtain requisite regulatory and other required approvals and the satisfaction of other conditions on the proposed terms and schedule; as future market conditions, changes in general economic and business conditions, the behaviour of other market participants, the anticipated benefits from the proposed transaction not being realised as a result of changes in general economic and market conditions in the countries in which the Funds operate, weak, volatile or illiquid capital and/or credit markets, changes in tax rates, interest rate and currency value fluctuations, the degree of competition in the geographic and business areas in which the Funds operate and changes in laws or in supervisory expectations or requirements.

 

Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. Such forward-looking statements should therefore be construed in the light of such factors. Neither MCIM nor the Funds, nor any of their respective associates or directors, officers or advisers, provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this announcement will actually occur. You are cautioned not to place any reliance on these forward-looking statements. Other than in accordance with their legal or regulatory obligations, neither MCIM nor the Funds is under any obligation, and they expressly disclaim any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This announcement speaks only as of the date issued.

 

For Markel CATCo investor inquiries, contact:

Mark Way

Telephone: +1 441-493-9001

 

For Public Fund investor inquiries, contact:

Numis

Hugh Jonathan

Telephone: +44 (0) 20 7260

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SOAFVLFLFBLBFBQ
Date   Source Headline
14th Oct 20147:00 amRNSNet Asset Value(s)
18th Sep 20143:40 pmRNSHolding(s) in Company
12th Sep 20147:00 amRNSNet Asset Value(s)
14th Aug 20142:41 pmRNSHalf Yearly Report
13th Aug 201412:22 pmRNSNet Asset Value(s)
31st Jul 20142:36 pmRNSHolding(s) in Company
10th Jul 20142:00 pmRNSNet Asset Value(s)
20th May 201411:28 amRNSTransaction in Own Shares
13th May 20147:00 amRNSNet Asset Value(s)
16th Apr 20144:25 pmRNSDirector/PDMR Shareholding
15th Apr 20147:00 amRNSHolding(s) in Company
10th Apr 20147:00 amRNSNet Asset Value(s)
28th Mar 20142:29 pmRNSAnnual General Meeting Results
17th Mar 201412:32 pmRNSCATCo launches traditional reinsurance fund
13th Mar 20142:41 pmRNSNet Asset Value(s)
6th Mar 20147:00 amRNSHolding(s) in Company
26th Feb 20144:15 pmRNSNon Mainstream Pooled Investments
24th Feb 20147:00 amRNSCATCo appointments strengthen underwriting team
19th Feb 20143:01 pmRNSNet Asset Value(s)
18th Feb 20143:50 pmRNSFinal Results
31st Jan 20144:55 pmRNSHolding(s) in Company
27th Jan 20143:31 pmRNSResolution Results of Special Meeting
27th Jan 20142:47 pmRNSResult of Special General Meeting
15th Jan 20142:09 pmRNSPortfolio Update
14th Jan 20147:00 amRNSContingent Distribution to Ordinary Shareholders
14th Jan 20147:00 amRNSDividend Declaration
14th Jan 20147:00 amRNSNet Asset Value(s)
3rd Jan 20147:00 amRNSProposed Return of Value to Shareholders
16th Dec 20134:08 pmRNSNet Asset Value(s)
6th Dec 20137:00 amRNSPossible Capital and Income Distribution
12th Nov 20134:05 pmRNSNet Asset Value(s)
12th Nov 201311:42 amRNSHolding(s) in Company
11th Oct 20137:00 amRNSNet Asset Value(s)
7th Oct 20134:34 pmRNSChange of Adviser
26th Sep 20134:22 pmRNSDirector/PDMR Shareholding
23rd Sep 201312:01 pmRNSDirector Declaration
11th Sep 20137:00 amRNSNet Asset Value(s)
15th Aug 20131:39 pmRNSHalf Yearly Report
13th Aug 20133:19 pmRNSHolding(s) in Company
13th Aug 20137:00 amRNSNet Asset Value(s)
11th Jul 20133:51 pmRNSNet Asset Value(s)
2nd Jul 20131:30 pmRNSChange of Independent Auditor
12th Jun 20137:00 amRNSNet Asset Value(s)
29th May 20132:53 pmRNSHurricane Sandy Update
23rd May 20131:54 pmRNSMidwestern Tornados Outbreak
22nd May 20131:00 pmRNSHolding(s) in Company
20th May 20134:39 pmRNSHolding(s) in Company
17th May 20132:38 pmRNSHolding(s) in Company
10th May 20135:15 pmRNSNet Asset Value(s)
12th Apr 20137:00 amRNSNet Asset Value - March 2013

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.